Grander D - Search Results

1

Targeting of distinct signaling cascades and cancer-associated fibroblasts define the efficacy of Sorafenib against prostate cancer cells.

Kharaziha P, Rodriguez P, Li Q, Rundqvist H, Björklund AC, Augsten M, Ullén A, Egevad L, Wiklund P, Nilsson S, Kroemer G, Grander D, Panaretakis T. Kharaziha P, et al. Among authors: grander d. Cell Death Dis. 2012 Jan 26;3(1):e262. doi: 10.1038/cddis.2012.1. Cell Death Dis. 2012. PMID: 22278289 Free PMC article.

2

Sorafenib induces apoptosis and autophagy in prostate cancer cells in vitro.

Ullén A, Farnebo M, Thyrell L, Mahmoudi S, Kharaziha P, Lennartsson L, Grandér D, Panaretakis T, Nilsson S. Ullén A, et al. Among authors: grander d. Int J Oncol. 2010 Jul;37(1):15-20. doi: 10.3892/ijo_00000648. Int J Oncol. 2010. PMID: 20514392

3

Alternative signaling pathways regulating type I interferon-induced apoptosis.

Pokrovskaja K, Panaretakis T, Grandér D. Pokrovskaja K, et al. Among authors: grander d. J Interferon Cytokine Res. 2005 Dec;25(12):799-810. doi: 10.1089/jir.2005.25.799. J Interferon Cytokine Res. 2005. PMID: 16375608 Review.

4

Autophagy: cancer therapy's friend or foe?

Grandér D, Panaretakis T. Grandér D, et al. Future Med Chem. 2010 Feb;2(2):285-97. doi: 10.4155/fmc.09.155. Future Med Chem. 2010. PMID: 21426194 Review.

5

Sorafenib has potent antitumor activity against multiple myeloma in vitro, ex vivo, and in vivo in the 5T33MM mouse model.

Kharaziha P, De Raeve H, Fristedt C, Li Q, Gruber A, Johnsson P, Kokaraki G, Panzar M, Laane E, Osterborg A, Zhivotovsky B, Jernberg-Wiklund H, Grandér D, Celsing F, Björkholm M, Vanderkerken K, Panaretakis T. Kharaziha P, et al. Among authors: grander d. Cancer Res. 2012 Oct 15;72(20):5348-62. doi: 10.1158/0008-5472.CAN-12-0658. Epub 2012 Sep 4. Cancer Res. 2012. PMID: 22952216

6

Sorafenib-induced defective autophagy promotes cell death by necroptosis.

Kharaziha P, Chioureas D, Baltatzis G, Fonseca P, Rodriguez P, Gogvadze V, Lennartsson L, Björklund AC, Zhivotovsky B, Grandér D, Egevad L, Nilsson S, Panaretakis T. Kharaziha P, et al. Among authors: grander d. Oncotarget. 2015 Nov 10;6(35):37066-82. doi: 10.18632/oncotarget.5797. Oncotarget. 2015. PMID: 26416459 Free PMC article.

7

Cell death induced by dexamethasone in lymphoid leukemia is mediated through initiation of autophagy.

Laane E, Tamm KP, Buentke E, Ito K, Kharaziha P, Oscarsson J, Corcoran M, Björklund AC, Hultenby K, Lundin J, Heyman M, Söderhäll S, Mazur J, Porwit A, Pandolfi PP, Zhivotovsky B, Panaretakis T, Grandér D. Laane E, et al. Among authors: grander d. Cell Death Differ. 2009 Jul;16(7):1018-29. doi: 10.1038/cdd.2009.46. Epub 2009 Apr 24. Cell Death Differ. 2009. PMID: 19390558

8

Activation of Bak, Bax, and BH3-only proteins in the apoptotic response to doxorubicin.

Panaretakis T, Pokrovskaja K, Shoshan MC, Grandér D. Panaretakis T, et al. Among authors: grander d. J Biol Chem. 2002 Nov 15;277(46):44317-26. doi: 10.1074/jbc.M205273200. Epub 2002 Aug 21. J Biol Chem. 2002. PMID: 12193597 Free article.

9

Interferon-alpha-induced apoptosis in U266 cells is associated with activation of the proapoptotic Bcl-2 family members Bak and Bax.

Panaretakis T, Pokrovskaja K, Shoshan MC, Grandér D. Panaretakis T, et al. Among authors: grander d. Oncogene. 2003 Jul 17;22(29):4543-56. doi: 10.1038/sj.onc.1206503. Oncogene. 2003. PMID: 12881711

10

Autophagy as the main means of cytotoxicity by glucocorticoids in hematological malignancies.

Grandér D, Kharaziha P, Laane E, Pokrovskaja K, Panaretakis T. Grandér D, et al. Autophagy. 2009 Nov;5(8):1198-200. doi: 10.4161/auto.5.8.10122. Epub 2009 Nov 18. Autophagy. 2009. PMID: 19855186

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

141 results

Search Page

Filters